Fiche société
Salvia BioElectronics
Traitements, essais et publications liés.
Traitements6programmes
Essais4liés
Publications5liées
SourceDBlocale
Traitements
6| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| NeurostimulatorThe purpose of this pivotal clinical study is to evaluate the safety and effectiveness of the MySalvia System, a minimally invasive implantable neuromodulation therapy, for the preventive treatment of adults with resistant migraine. | Migraine | Non applicable | À vérifier | United States | À vérifier |
| PRIMUSThe purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine. | Migraine | Non applicable | À vérifier | Australia, Belgium, Netherlands | À vérifier |
| NeurostimulatorThe purpose of this pivotal clinical study is to evaluate the safety and effectiveness of the MySalvia System, a minimally invasive implantable neuromodulation therapy, for the preventive treatment of adults with resistant migraine. | Migraine | Non applicable | À vérifier | United States | À vérifier |
| PRIMUSThe purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine. | Migraine | Non applicable | À vérifier | Australia, Belgium, Netherlands | À vérifier |
| PRIMUSThe purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine. | Migraine | Non applicable | À vérifier | Belgium | À vérifier |
| NeurostimulatorThe purpose of this pivotal clinical study is to evaluate the safety and effectiveness of the MySalvia System, a minimally invasive implantable neuromodulation therapy, for the preventive treatment of adults with resistant migraine. | Migraine | Non applicable | À vérifier | United States, Australia | À vérifier |
Essais cliniques
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Neurostimulator | Migraine | Non applicable | NCT06167655 | A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM | ACTIVE_NOT_RECRUITING |
| PRIMUS | Migraine | Non applicable | NCT05858801 | SalviaBio — First Evaluation of a Craniofacial Nerve Stimulation System in Chronic Migraine | ACTIVE_NOT_RECRUITING |
| PRIMUS | Migraine | Non applicable | NCT06450444 | The RECLAIM Study. | RECRUITING |
| Neurostimulator | Migraine | Non applicable | NCT07719608 | RECLAIM-II — A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine | RECRUITING |
Publications
5| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| PRIMUS | Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation. | Obesity pillars | ||
| PRIMUS | Multidimensional burden of scarring alopecia in women: findings from the CAPAIR study. | International journal of women's dermatology | ||
| Neurostimulator | A profile on the Cefaly Dual trigeminal neurostimulator for acute and preventive migraine treatment: an overview of its safety and efficacy. | Expert review of medical devices | ||
| Neurostimulator | Preoperative Hyperglycemia in GYN Surgery: Perioperative Considerations. | Obstetrical & gynecological survey | ||
| Neurostimulator | Electrode Type and Long-Term Clinical Response to Responsive Neurostimulation: A Single-Center Cohort With 5-Year Follow-up. | Neurosurgery |